Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumorsElliot Kahen, Damon R. Reed(Moffitt Cancer Center)OncotargetApril 27, 201810.18632/oncotarget.25181Cited by 33SaveCiteExport RISWatch citationsRelated PapersIdentification of Selective ATP-Competitive CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function|Research Square|2023|3